Research and Markets (http://www.researchandmarkets.com/research/lmglxg/chronic) has announced the addition of the "Chronic Bronchitis-Pipeline Insights, 2014" subscription to their offering.
This Chronic Bronchitis-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chronic Bronchitis.
This report provides information on the therapeutic development based on the Chronic Bronchitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Chronic Bronchitis Overview
- Chronic Bronchitis Pipeline Therapeutics
- Chronic Bronchitis Therapeutics under Development by Companies
- Chronic Bronchitis Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Chronic Bronchitis Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Chronic Bronchitis Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Chronic Bronchitis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Chronic Bronchitis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Chronic Bronchitis - Discontinued Products
- Chronic Bronchitis - Dormant Products
- Companies Involved in Therapeutics Development for Chronic Bronchitis
- Appendix
For more information visit http://www.researchandmarkets.com/research/lmglxg/chronic